FDA Inspection 1102447 — Pacira Pharmaceuticals, Inc.
The FDA completed an inspection of Pacira Pharmaceuticals, Inc. on September 6, 2019 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 6, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- San Diego, CA (United States)